Effect of Sodium Nitroprusside on Mortality in Acute Myocardial Infarction

Authors:
  • JDJoseph D. Durrer
    Joseph D. Durrer
  • KLKong Ing Lie
    Kong Ing Lie
  • FCFrans J. L. van Capelle
    Frans J. L. van Capelle
  • DDDirk Durrer
    Dirk Durrer

Abstract
We gave sodium nitroprusside by intravenous infusion to 163 randomly selected patients during the first 24 hours after hospitalization for typical acute myocardial infarction, and we studied its effects on mortality at one week, on the incidence of cardiogenic shock, on clinical signs of left ventricular failure, and on peak levels of creatine kinase isoenzyme MB. A control group of 165 patients received standard medical treatment and infusion of 5 per cent glucose. The end point of the study was a significant reduction in mortality in the nitroprusside group; this was reached when five deaths had occurred in this group, as compared with 18 among the controls (P<0.05). The incidence of cardiogenic shock, clinical signs of left-heart failure, and mean peak levels of creatine kinase isoenzyme MB were all reduced (P<0.05). The results indicate that infusion of nitroprusside in the early phase of acute infarction limits complications, possibly by reducing infarct size. The drug was particularly effective in anterior-wall infarction. (N Engl J Med. 1982; 306:1121–8.)

This publication has 28 references indexed in Scilit: